
A recent op-ed notes that the California Drug Price Relief Act is a distraction from anti-fraud measures. Backing California’s already…
A recent op-ed notes that the California Drug Price Relief Act is a distraction from anti-fraud measures. Backing California’s already…
North Carolina lawmakers are investigating insurers’ “fail first” policies, a common practice in which patients are required to first try…
Oral chemotherapy treatments are often more effective and less invasive than IV chemotherapy treatments. Yet, many cancer patients throughout the…
Florida Governor Rick Scott has allocated $5 million of his proposed state budget for the creation and development of a…
Scientists are making incredible progress in treating cancer, as evidenced by former president Jimmy Carter’s successful melanoma treatment earlier this…
According to a new federal report, health care spending grew 5.3 percent last year to $3 trillion. This jump in…
Employers have great potential to influence distribution, purchasing and brokerage actors to address rising health care costs. With patients unable…
Former New York Congressman Dan Maffei pens an op-ed in The Hill urging leaders in his party to avoid targeting…
In his recent commentary, Robert Goldberg argues the “value-based” pricing approach being taken by a small group of doctors would…
Hillary Clinton’s presidential campaign released a new television ad highlighting her proposal to address rising prescription drug prices. Clinton is…